The Philippines has breached the eight-million mark in the number of Covid-19 jabs administered.
Data from the National Vaccination Operations Center showed that, as of June 18, a total of 8,050,711 jabs have been administered nationwide.
Of the total, 5,953,810 were given as the first dose.
National Task Force Against Covid-19 chief implementer, Secretary Carlito Galvez Jr., who announced the data yesterday, said there will be no letup in the national vaccination campaign.
“All sectors of society are working together so that we can start to move on from this pandemic, bring back a greater sense to our lives, and further open up our economy,” he said.
“Local government units and the private sector are playing key roles in this effort, as they ramp up the inoculation of their citizens and employees, respectively. They are really doing an amazing job and we would like to laud them for their hard work,” he added.
To date, 94.24 percent or 1,053,373 health care workers (A1) have been inoculated while in the senior citizens (A2) group, 1,939,599 have received their first dose and 536,476 have been fully vaccinated.
For adults with comorbidities (A3), 2,005,206 have been given their first jabs while 498,925 have received both shots.
For the economic frontliners (A4), 452,600 were administered their first dose, while 8,127 are already fully vaccinated.
The vaccination of the A4 category began on June 7 but is limited to the National Capital Region, Metro Cebu, Metro Davao, Bulacan, Batangas, Cavite, Laguna, Pampanga, and Rizal where there are a significant number of Covid-19 cases.
At least 23,826 indigent residents were also given their first dose in select LGUs in NCR.
“We’re now seeing an upward trajectory in the vaccination across all priority groups. This is a very good indication that vaccine hesitancy is being addressed and more Filipinos, especially our senior citizens, are now willing to get inoculated,” Galvez said.
“We are happy that the public uptake for Sinovac has also increased significantly. The steady supply of doses particularly of this brand, will enable us to fast-track the inoculation of the A4 priority group, as well as provide much-needed vaccines to emerging hotspots across the country,” he added.*PNA